| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:ALK5-IN-6
CAS:2657720-04-0
Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
Quinoline, 4-[[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-6-methoxy-7-[3-(4-morpholinyl)propoxy]- manufacturers
- ALK5-IN-6
-
- $1520.00 / 25mg
-
2025-10-27
- CAS:2657720-04-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Quinoline, 4-[[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-6-methoxy-7-[3-(4-morpholinyl)propoxy]- Basic information |
| | Quinoline, 4-[[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-6-methoxy-7-[3-(4-morpholinyl)propoxy]- Chemical Properties |
| Boiling point | 674.0±55.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | pka | 7.01±0.10(Predicted) |
| | Quinoline, 4-[[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-6-methoxy-7-[3-(4-morpholinyl)propoxy]- Usage And Synthesis |
| Uses | ALK5-IN-6 is a potent inhibitor of ALK5. Transforming growth factor beta (TGF-β) is a multifunctional cytokine that is involved in regulating cell proliferation, differentiation and apoptosis through complex receptor signaling pathways on the cell surface in an autocrine, paracrine and endocrine manner. ALK5-IN-6 has the potential for the research of TGF-β-related diseases and conditions, including but not limited to tumors, fibrotic diseases, inflammatory diseases, autoimmune diseases, etc (extracted from patent WO2021129621A1, compound 1)[1]. | | References | [1] Tang Feng, et al. Pyrazoles. Patent WO2021129621A1. |
| | Quinoline, 4-[[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-6-methoxy-7-[3-(4-morpholinyl)propoxy]- Preparation Products And Raw materials |
|